Literature DB >> 35588933

Psychedelic resting-state neuroimaging: A review and perspective on balancing replication and novel analyses.

Drummond E-Wen McCulloch1, Gitte Moos Knudsen2, Frederick Streeter Barrett3, Manoj K Doss4, Robin Lester Carhart-Harris5, Fernando E Rosas6, Gustavo Deco7, Morten L Kringelbach8, Katrin H Preller9, Johannes G Ramaekers10, Natasha L Mason10, Felix Müller11, Patrick MacDonald Fisher12.   

Abstract

Clinical research into serotonergic psychedelics is expanding rapidly, showing promising efficacy across myriad disorders. Resting-state functional magnetic resonance imaging (rs-fMRI) is a commonly used strategy to identify psychedelic-induced changes in neural pathways in clinical and healthy populations. Here we, a large group of psychedelic imaging researchers, review the 42 research articles published to date, based on the 17 unique studies evaluating psychedelic effects on rs-fMRI, focusing on methodological variation. Prominently, we observe that nearly all studies vary in data processing and analysis methodology, two datasets are the foundation of over half of the published literature, and there is lexical ambiguity in common outcome metric terminology. We offer guidelines for future studies that encourage coherence in the field. Psychedelic rs-fMRI will benefit from the development of novel methods that expand our understanding of the brain mechanisms mediating its intriguing effects; yet, this field is at a crossroads where we must also consider the critical importance of consistency and replicability to effectively converge on stable representations of the neural effects of psychedelics.
Copyright © 2022 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Ayahausca; Clinical; DMT; Entheogen; FMRI; Hallucinogen; Human; LSD; Neuroimaging; Psilocin; Psilocybin; Psychedelic; Replication; Resting-state; Serotonin

Mesh:

Substances:

Year:  2022        PMID: 35588933     DOI: 10.1016/j.neubiorev.2022.104689

Source DB:  PubMed          Journal:  Neurosci Biobehav Rev        ISSN: 0149-7634            Impact factor:   9.052


  2 in total

1.  Your brain on psychedelics.

Authors:  Liam Drew
Journal:  Nature       Date:  2022-09       Impact factor: 69.504

Review 2.  Neuroimaging Correlates of Treatment Response with Psychedelics in Major Depressive Disorder: A Systematic Review.

Authors:  Sarah Kuburi; Anne-Marie Di Passa; Vanessa K Tassone; Raesham Mahmood; Aleksandra Lalovic; Karim S Ladha; Katharine Dunlop; Sakina Rizvi; Ilya Demchenko; Venkat Bhat
Journal:  Chronic Stress (Thousand Oaks)       Date:  2022-08-02
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.